Search
Search Results
##search.searchResults.foundPlural##
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2572PDF: 797HTML: 5207 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3750PDF: 1649HTML: 11566Figures Haase: 194 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1671PDF: 801HTML: 934cover letter: 264 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3225PDF: 1330HTML: 4129 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3925PDF: 1489HTML: 9187Untitled: 273Untitled: 179Untitled: 166Untitled: 162Untitled: 177Untitled: 335 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
467PDF: 241HTML: 77 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2059PDF: 1112HTML: 7689cover letter paper final AML: 213 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1028PDF: 1150Suppl. Files: 569HTML: 82 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1773PDF: 964HTML: 140 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1752PDF: 562HTML: 275 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1340PDF: 813HTML: 5033INSTITUTE PUBLICATION COMMITTEE APPROVAL: 159 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1508PDF: 529HTML: 267 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3498PDF: 877HTML: 1650figure 1: 161Untitled: 187 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2440PDF: 783HTML: 1735 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2186PDF: 796HTML: 1626Figure 1: 180Table 1: 202 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1596PDF: 801HTML: 160 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1946PDF: 708HTML: 679Table1: patient's characteristics: 154Table 2: profile of each patient: 178 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2675PDF: 763HTML: 214 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4306PDF: 1754HTML: 1106 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1449PDF: 757Suppl. Files: 320Html: 133 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2244PDF: 830HTML: 2134New table Chinese children with APL: 160 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3865PDF: 751HTML: 1846 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1977PDF: 1120HTML: 615 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1297PDF: 1192HTML: 445 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1471PDF: 761HTML: 200 -
Osteolytic bone lesions – A rare presentation of AML M6.
1964PDF: 1093HTML: 7922Untitled: 202 -







